Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research
- PMID: 19629749
- DOI: 10.1007/s11019-009-9192-0
Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research
Abstract
Ex-vivo tissue engineering is a quickly developing medical technology aiming to regenerate tissue through the introduction of an ex-vivo created tissue construct instead of restoring the damaged tissue to some level of functionality. Tissue engineering is considered by some as a new medical paradigm. We analyse this claim and identify tissue engineering's fundamental characteristics, focusing on the aim of the intervention and on the complexity and continuity of the process. We inquire how these features have an impact not only on the scientific research itself but also on the ethical evaluation of this research. We suggest that viewing tissue engineering as a new medical paradigm allows us to develop a wider perspective for successful investigation instead of focusing on isolated steps of the tissue engineering process in an anecdotal way, which may lead to an inadequate ethical evaluation. We argue that the concept of tissue engineering as a paradigm may benefit the way we address the ethical challenges presented by tissue engineering.
Similar articles
-
Ethical reflections on clinical trials with human tissue engineered products.J Med Ethics. 2008 Sep;34(9):e1. doi: 10.1136/jme.2007.022913. J Med Ethics. 2008. PMID: 18757609
-
Ethical considerations in the translation of regenerative biofabrication technologies into clinic and society.Biofabrication. 2016 Oct 7;8(4):042001. doi: 10.1088/1758-5090/8/4/042001. Biofabrication. 2016. PMID: 27716629 Free PMC article. Review.
-
Engineering flesh: towards an ethics of lived integrity.Med Health Care Philos. 2008 Sep;11(3):269-83. doi: 10.1007/s11019-007-9115-x. Epub 2008 Feb 5. Med Health Care Philos. 2008. PMID: 18247157 Free PMC article.
-
Sustainable bioinspired materials for regenerative medicine: balancing toxicology, environmental impact, and ethical considerations.Biomed Mater. 2024 Oct 18;19(6). doi: 10.1088/1748-605X/ad85bb. Biomed Mater. 2024. PMID: 39389102 Review.
-
Ethical considerations in tissue engineering research: Case studies in translation.Methods. 2016 Apr 15;99:135-44. doi: 10.1016/j.ymeth.2015.08.010. Epub 2015 Aug 14. Methods. 2016. PMID: 26282436 Free PMC article. Review.
Cited by
-
In risk we trust/Editing embryos and mirroring future risks and uncertainties.Med Health Care Philos. 2019 Jun;22(2):191-200. doi: 10.1007/s11019-018-9851-0. Med Health Care Philos. 2019. PMID: 30229357
-
Early-Phase Clinical Trials of Bio-Artificial Organ Technology: A Systematic Review of Ethical Issues.Transpl Int. 2022 Oct 31;35:10751. doi: 10.3389/ti.2022.10751. eCollection 2022. Transpl Int. 2022. PMID: 36388425 Free PMC article.
-
The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review.Tissue Eng Part B Rev. 2023 Apr;29(2):167-187. doi: 10.1089/ten.TEB.2022.0033. Epub 2022 Oct 20. Tissue Eng Part B Rev. 2023. PMID: 36112697 Free PMC article.
-
Ethics of Early Clinical Trials of Bio-Artificial Organs.Transpl Int. 2022 Jul 6;35:10621. doi: 10.3389/ti.2022.10621. eCollection 2022. Transpl Int. 2022. PMID: 35874305 Free PMC article.
-
Stem cell trials for cardiovascular medicine: ethical rationale.Tissue Eng Part A. 2014 Oct;20(19-20):2567-74. doi: 10.1089/ten.TEA.2013.0332. Epub 2013 Dec 11. Tissue Eng Part A. 2014. PMID: 24164351 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources